Short-Read Sequencing Market to Grow with a CAGR of 13.89% through 2029
Rising
prevalence of genetic disorders and cancers is expected to drive the Global
Short-Read Sequencing Market growth in the forecast period, 2025-2029.
According
to TechSci Research report, “Short-Read Sequencing Market – Global Industry
Size, Share, Trends, Competition Forecast & Opportunities, 2029F”,
the Global Short-Read Sequencing Market stood at USD 5.42 Billion in 2023 and
is anticipated to grow with a CAGR of 13.89% in the forecast period,
2025-2029.The rising prevalence of genetic disorders and cancers worldwide is
driving the adoption of short read sequencing technologies in clinical
diagnostics. NGS-based tests offer comprehensive genomic profiling that can aid
in the early detection, diagnosis, and management of genetic diseases and
cancer subtypes. Additionally, short read sequencing facilitates the
identification of actionable mutations and genetic predispositions, enabling
precision medicine approaches for personalized treatment strategies. With the
increasing burden of genetic diseases and cancers, there is a growing need for
accurate and cost-effective sequencing solutions, thereby fueling market
growth.
Advancements in oncology research are
driving the adoption of short read sequencing technologies in clinical
diagnostics. Genomic profiling of tumors using short read sequencing can inform
precision oncology approaches, enabling clinicians to tailor treatment regimens
to individual patients based on their genomic profile. As precision medicine
continues to gain traction in oncology, the demand for short read sequencing
technologies in clinical diagnostics is expected to escalate, driving market
growth and innovation.
Browse
over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Short-Read Sequencing Market”
The
Global Short-Read Sequencing Market is segmented into product, application, end-user,
regional distribution, and company.
Based on the Product, Consumables
segment emerged as the dominant segment in the Global Short-Read Sequencing
market in 2023. As the number of sequencing experiments conducted worldwide
continues to rise, the consumption of consumables also increases proportionally,
driving market growth in this segment. Technological advancements
and innovations in short-read sequencing platforms have led to the development
of new and improved consumables with enhanced performance and efficiency.
companies are developing novel reagents and kits that enable faster library
preparation, higher sequencing throughput, and improved data quality, catering
to the evolving needs of researchers and clinicians. The
competitive pricing and availability of consumables from multiple vendors
further contribute to the dominance of the Consumables segment in the Global
Short-Read Sequencing market.
Based
on the Application, targeted sequencing & resequencing segment emerged as
the dominant segment in the Global Short-Read Sequencing market in 2023. Advancements in sequencing technologies and bioinformatics tools
have made targeted sequencing more accessible and cost-effective, driving
adoption across research institutions, clinical laboratories, and biotechnology
firms. Companies are developing innovative targeted sequencing assays, panels,
and kits that offer high specificity, sensitivity, and coverage, catering to
the diverse needs of researchers and clinicians. The versatility of
targeted sequencing and resequencing makes it applicable across a wide range of
research and clinical applications, including cancer profiling, genetic
screening, infectious disease diagnosis, and agricultural genomics. This broad
applicability further contributes to the dominance of the targeted sequencing
and resequencing segment in the Global Short-Read Sequencing market.
North
America emerged as the dominant player in the Global Short-Read Sequencing
Market in 2023, holding the largest market share. North America benefits from a
strong network of healthcare institutions and clinical laboratories that
leverage short-read sequencing technologies for genomic analysis, clinical
diagnostics, and personalized medicine applications. The region's advanced
healthcare infrastructure, coupled with high healthcare expenditure and
reimbursement policies, encourages the adoption of genomic technologies in
clinical settings, driving market demand. Additionally, strategic
collaborations and partnerships between industry players, academic
institutions, and healthcare organizations in North America have facilitated
technology transfer, knowledge exchange, and market expansion. These
collaborations have accelerated the development and commercialization of
innovative sequencing solutions tailored to the diverse needs of researchers,
clinicians, and patients in the region.
Major
companies operating in Global Short-Read Sequencing Market are:
- Illumina,
Inc.
- Invitae
Corporation
- Thermo
Fisher Scientific, Inc.
- Pacific
Biosciences of California, Inc.
- BGI
Genomics Co., Ltd
- QIAGEN
NV
- Agilent
Technologies
- Azenta
US, Inc. (GENEWIZ)
- PerkinElmer,
Inc.
- ProPhase
Labs, Inc. (Nebula Genomics)
Download Free Sample Report
Customers
can also request for 10% free customization on this report
“The
Global Short-Read Sequencing Market is poised for significant growth in the
coming years. Technological advancements, such as improvements in sequencing
platforms and bioinformatics tools, are enhancing the accuracy, speed, and
affordability of short-read sequencing. Additionally, the rising demand for
personalized medicine and precision healthcare is fueling the adoption of
short-read sequencing technologies for genomic profiling and targeted
therapies. The increasing prevalence of genetic disorders, cancers,
and infectious diseases worldwide is driving the need for comprehensive genomic
analysis in research and clinical diagnostics in the expansion of
short-read sequencing applications in non-clinical sectors, such as agriculture,
forensics, and environmental monitoring, is creating new opportunities for
market growth.” said Mr. Karan Chechi, Research Director, TechSci Research,
a research-based management consulting firm.
“Short-Read Sequencing Market - Global
Industry Size, Share, Trends, Opportunity, and Forecast, Segmented
By Product (Instruments, Consumables, Services), By Application (Whole Genome
Sequencing, Whole Exome Sequencing, Targeted Sequencing & Resequencing,
Others), By End User (Academic & Research Institutes, Hospitals &
Clinics, Pharmaceutical & Biotechnology Companies, Others), By Region and
Competition, 2020-2030F”, has evaluated the future growth potential of Global
Short-Read Sequencing Market and provides statistics & information on
market size, structure and future market growth. The report intends to provide
cutting-edge market intelligence and help decision makers take sound investment
decisions. Besides, the report also identifies and analyzes the emerging trends
along with essential drivers, challenges, and opportunities in Global
Short-Read Sequencing Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com